MATTHEY OSTER
Euromonitor International, Chicago, USA

Abstract

In 2017, dietary supplements with bone or joint health positioning represented over USD9 billion globally, constituting almost 16% of the global market for dietary supplements. Though bone/joint health supplements are still on top of the global dietary supplement marketplace, digging inside the numbers presents a more complicated picture about the development of this category in the near future.

In 2017, dietary supplements with bone or joint health positioning represented over USD9 billion globally, constituting almost 16% of the global market for dietary supplements. Combined, bone/joint health remains the largest single health positioning worldwide, outpacing immune system support, digestive health, heart health and beauty positioning, but lower than dietary supplements with no overt positioning or positioned around general health, which represented more than USD12 million in 2017.

Though bone/joint health supplements are still on top of the global dietary supplement marketplace, digging inside the numbers presents a more complicated picture about the development of this category in the near future. On the one hand, one can look at recent growth to support the contention that the bone/joint marketplace has reached a bit of a plateau compared with the industry as a whole (growth CAGR for the period between 2012 and 2017 was less than 1% compared with 2.7% for the full dietary supplements market). As a result, bone/joint health has declined from almost 19% of the global dietary supplements market in 2008 to 15.8% in 2017.
As the marketplace for dietary ...